COMPASS Pathways plc (NASDAQ:CMPS) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET
Company Participants
Steve Schultz - SVP, IR
Kabir Nath - CEO
Teri Loxam - CFO
Guy Goodwin - Chief Medical Officer
Steve Levin - Chief Patient Officer
Conference Call Participants
Paul Matteis - Stifel
Charles Duncan - Cantor Fitzgerald
Athena Chin - TD Cowen
Sumant Kulkarni - Canaccord Genuity
Patrick Trucchio - H.C. Wainwright
Operator
Ladies and gentlemen, thank you for standing by. And welcome to the COMPASS Pathways First Quarter 2025 Earnings Call. Please note that this call is being recorded. After the speakers' prepared remarks, there will be a question-and-answer session [Operator Instructions]. I'd now like to hand the call over to Steve Schultz, Senior Vice President of Investor Relations. You may now begin, sir.
Steve Schultz
Welcome all of you. And thank you for joining us today for our first quarter 2025 results conference call. Again, my name is Steve Schultz, Senior Vice President of Investor Relations at COMPASS Pathways. Today, I'm joined by Kabir Nath, our Chief Executive Officer; and Teri Loxam, our Chief Financial Officer, who will have prepared remarks. In addition, Dr. Guy Goodwin, our Chief Medical Officer; and Dr. Steve Levin, our Chief Patient Officer, will be available for the Q&A. The call is being recorded and will be available on the COMPASS Pathways' Investor Relations Web site shortly after the conclusion of the call and will be available for a period of 30 days. Before we begin, let me remind everyone that during the call today, the team will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as amended. You should not place undue reliance on these forward-looking statements. Actual events or results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and and other factors, including those risks and uncertainties described under the heading Risk
- Read more current CMPS analysis and news
- View all earnings call transcripts